Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22563981 | 0.86 | SIGMAR1 (0.41) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563828 | 0.85 | SIGMAR1 (0.40) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL19909874 | 0.85 | SIGMAR1 (0.40) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563896 | 0.84 | SIGMAR1 (0.40) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563942 | 0.84 | SIGMAR1 (0.39) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563770 | 0.83 | SIGMAR1 (0.39) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563755 | 0.83 | SIGMAR1 (0.39) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22563978 | 0.83 | SIGMAR1 (0.41) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL19909876 | 0.82 | SIGMAR1 (0.40) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL22564121 | 0.82 | SIGMAR1 (0.38) | SIGMAR1NR1H4ALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |